Nanopharma
Nanopharma is a Czech specialty materials company that designs and manufactures customized electrospun nanofiber structures for cosmetics (NanoBeauty face masks), life-science research scaffolds (NanoMatrix 3D), and industrial/medical applications, operating a hybrid model of contract R&D services, branded products, and technology licensing.
- Company typePrivate
- Founded2008
- HeadquartersPardubice, Czechia
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Nanopharma does
Nanopharma, a.s. is a Czech specialty materials engineering company founded in 2008 and headquartered in Pardubice, with R&D laboratories co-located at the Technical University of Liberec and a commercial contact point in Prague. The company specializes in electrospinning — the electrostatic production of polymer nanofibers — using a broad portfolio of methods including needle, needleless, coaxial, AC, and centrifugal spinning. Its nanofibrous structures are customized into 2D and 3D formats and applied across cosmetics (the NanoBeauty dry face mask product line launched in 2022), life-science research (the NanoMatrix 3D scaffold line), medical device and implantology R&D (via the CzechImplant cluster), and industrial filtration and sensing applications.
The business model is hybrid and operates across four revenue streams: (1) project-based custom R&D and contract research services for industrial and academic partners; (2) licensing and know-how transfer of production processes through the Technology Solutions division; (3) branded product sales — NanoBeauty nanofibrous face masks sold via a dedicated e-commerce storefront (nanobeauty.cz) and OEM/ODM/private-label arrangements; and (4) direct sale of NanoMatrix 3D scaffolds to research institutions. Go-to-market is sales-led, combining named B2B contact points (e.g., Marek Čihák for wholesale, Johana Kulhánková for product development), trade-fair presence (FOR BEAUTY, Beauty Forum Praha), and consortium-based engagement via the NANOPROGRESS, Nanoasociace, and CzechImplant clusters.
The company employs 13 full-time team members (predominantly Ph.D.-level researchers from Technical University of Liberec's nanofiber department), holds 4 international patents including a 2023 European patent for electrostatically laminated nanofiber cosmetics, and has reported 50+ industry cooperations and 100+ closed orders over its 16-year operating history. Key customers are not publicly named; the segment mix spans cosmetics brands (primary), medical-device and pharmaceutical companies, industrial manufacturers, and Czech/European research institutions. No revenue, funding, or ownership figures have been disclosed.
Nanopharma firmographics
Firmographics- Name
- Nanopharma
- Legal name
- Nanopharma, a.s.
- Website
- https://nanopharma.cz
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Nanopharma is a Czech specialty materials company that designs and manufactures customized electrospun nanofiber structures for cosmetics (NanoBeauty face masks), life-science research scaffolds (NanoMatrix 3D), and industrial/medical applications, operating a hybrid model of contract R&D services, branded products, and technology licensing.
- Ownership category
- akta.pro rank
Nanopharma industry classification
Industry- Product category
- Nanomaterials engineering
- NAICS
- Research and Development in Nanotechnology (541713), Plastics Product Manufacturing (3261), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Plastics Products, Nec (3089), Biological Products, (No Disgnostic Substances) (2836), Miscellaneous Plastics Products (3080)
- akta.pro primary industry
- Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials) (HLAAAGAB)
- akta.pro secondary industries
- Bioplastics Compounding & Masterbatch (bio-based additives, colorants, fillers) (IMANANAB), Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Compostable & Bio-based Flexible Films and Sheet (extrusion/cast/blown) (IMANANAC)
Keywords
Where Nanopharma is headquartered
LocationHeadquarters
- HQ city
- Pardubice
- HQ country
- Czechia
- HQ region
- Europe
Offices3 records
Markets served
Nanopharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Custom R&D and contract research services: Nanopharma acts as a research and development partner for industrial and research organizations, delivering custom nanofiber material solutions from concept to pilot testing. Revenue is generated through project-based contracts for R&D services, material characterization, and experimental validation.
- Technology licensing and know-how transfer: The Technology Solutions division offers sale of technological processes for product fabrication in the form of licenses and production know-how, including implementation and subsequent service.
- NanoBeauty cosmetic products: Nanopharma manufactures and sells its own branded nanofibrous cosmetic face masks (NanoBeauty product line) and potentially sublingual strips, with revenue from product sales. Offers contract manufacturing, private label (OEM/ODM), co-branding and licensing arrangements.
- NanoMatrix 3D scaffolds: Sale of NanoMatrix 3D nanofibrous scaffolds for research, differentiation, in vitro expansion and cultivation of cells, for research and experimental purposes in life sciences.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B contract manufacturing and private label services — quote-based |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels4 records
Nanopharma product offering
Product offeringCore offering
Nanopharma is a nanomaterials engineering company that researches, develops, and produces customized nanofibrous structures using proprietary electrospinning technologies applied to natural and synthetic polymers. Its commercial offering combines contract research and contract manufacturing services (Technology Solutions division), branded nanofibrous cosmetic face masks under NanoBeauty, and NanoMatrix 3D biodegradable scaffolds for life science research, supported by in-house material characterization, biological testing, and skin diagnostics.
Product overview
Nanopharma is a technology company specializing in nanomaterials engineering, particularly nanofiber structures. The company operates two main divisions: (1) Product portfolio including NanoBeauty nanofiber face masks for cosmetics and NANOMATRIX 3D scaffolds for 3D cell cultivation research; (2) Services division encompassing custom nanofiber development and production, material characterization, biological testing, and skin diagnostics. The Technology Solutions division offers expert R&D services, experimental validation, pilot testing, and technology licensing. The company serves industry, cosmetics, and healthcare sectors with applications ranging from cosmetic products to medical devices and industrial filtration.
Differentiator
Problem solved
Functional benefit
Brands
- NanoBeauty: Nanofiber cosmetic face masks and skincare products - dry water-less skincare cosmetics, nanofiber patches and plasters, offered under Private Brand Label, OEM/ODM, Co-branding and licensing models.
- NanoMatrix 3D
Products and services
- NanoBeauty Nanofiber Face Masks Dry, water-less skincare cosmetic masks made from nanofibers with controlled release systems, produced from active ingredients without added preservatives and positioned as alternatives to gels, ointments, and creams. Offered to cosmetics brands via contract manufacturing, Private Brand Label, OEM/ODM, co-branding, and licensing.
- NanoMatrix 3D Scaffolds 3D nanofibrous cell cultivation scaffolds made from PCL, PLA, and PLCG biodegradable polymers, designed for research on cell differentiation, in vitro expansion, and cultivation of cells. Sold to Czech and European research centers for research, developmental, and experimental purposes.
- Technology Solutions by Nanopharma Expert services in research, development, experimental validation, and pilot testing of customized material solutions, including verification of technological and economic feasibility, processing of innovation projects, and sale of technological processes via licenses and production know-how with implementation and subsequent service.
- Custom Nanofiber Development and Production Services Custom development and manufacturing of nanofiber materials using multiple electrospinning technologies including electrostatic spinning, needleless electrospinning, coaxial electrospinning, AC spinning, and centrifugal spinning for industrial, biomedical, and cosmetic customers.
- Material Characterization Services Comprehensive characterization of polymer solutions and nanofibrous layers including scanning electron microscopy imaging, fiber diameter and porosity measurement, contact angle and surface energy measurement, degradation testing, mechanical testing, and HPLC analysis.
- Biological Testing Services Cell-based testing services for cosmetic and healthcare materials including cytotoxicity testing, cell adhesion and proliferation testing via optical microscopy, metabolic activity measurement, and fluorescence microscopy.
- Multi Skin Center Test Skin Diagnostics Professional in-house skin diagnostics service for verifying cosmetic product effectiveness, including skin hydration measurement, skin elasticity measurement, wrinkle measurement, and scalp measurement.
Quantifiable outcome
- 4 patents of international reach
- +2 more outcomes
Companies that use Nanopharma
Customer profileSegments4 records
Ideal customer profiles4 records
Nanopharma technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Nanopharma partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered minor and core.
- CzechImplant cluster (CZECHIMPLANT z.s.)minorNanopharma is a co-founding member of CzechImplant, established at the end of 2016 as the first medical cluster in the Czech Republic focused on implantology. The cluster supports the development of implantology in the Czech Republic and creates the best conditions for cooperation among members, particularly in research, development, and implementation of development results into practice.
- Association of the Nanotechnology Industry of the Czech Republic (Nanoasociace)coreNanopharma is a member of the Association of the Nanotechnology Industry of the Czech Republic (Nanoasociace), founded on 27 November 2014. The association brings together Czech companies from various industries including textiles, biotechnology, environmental applications, optics, and energy that have nanotechnology as their key business.
- SINBIO biotechnology groupminorNanopharma joined the SINBIO biotechnology group in 2011, providing access to biotechnology networks and collaborative research opportunities in the biotech sector.
- NANOPROGRESS clustercoreNanopharma is a founding member of NANOPROGRESS, the leading Czech nanotechnological cluster, established in 2010. The cluster is recognized as an excellent European cluster focused on research and development of functionalized nanofibrous structures and their applications in industry and biomedicine. Nanopharma collaborates with other members on collective research projects in the area of preparing and applying nanofiber materials, and benefits from the Ministry of Industry and Trade's Cluster Cooperation Program.
- Institute for Nanomaterials, Advanced Technology and Innovation (CXI), Technical University of LibereccoreNanopharma's laboratories are located at CXI, the Institute for Nanomaterials, Advanced Technology and Innovation at the Technical University of Liberec. Many team members (including Ph.D. researchers) have academic backgrounds from this institution. The partnership provides access to advanced research infrastructure and enables joint research projects.
Scale indicators7 records
Recent moves11 records
Expansion highlights6 records
Nanopharma competitors and assessment
Company assessmentDirect peers
- Nanofiber Solutions: US-based company developing electrospun nanofiber scaffolds for 3D cell culture, tissue engineering, and regenerative medicine. Direct peer in the NanoMatrix 3D scaffolds category, serving the same life sciences research customer base with similar biodegradable polymer technology.
- Elmarco: Czech-based manufacturer of industrial-scale needleless electrospinning equipment and nanofiber production lines. Direct peer in electrospinning technology for industrial and biomedical applications, operating from the same country and competing for similar enterprise customers.
- Finetex Envision: UK-based developer of electrospun nanofiber materials for filtration, healthcare, and energy applications. Direct competitor in custom nanofiber development using electrospinning, with overlapping customer segments in industrial filtration and biomedical materials.
- SNS Nano Fiber Technology: US-based manufacturer of nanofiber materials and electrospinning equipment for filtration, defense, and biomedical applications. Comparable in offering both custom nanofiber development services and proprietary nanofiber products to industrial buyers.
Broad incumbents
- Asahi Kasei (Bemliese/Velutis nanofiber): Large Japanese chemical conglomerate with a nanofiber non-woven materials business (Bemliese cellulose nanofiber) targeting cosmetics, hygiene, and industrial applications. Broad incumbent with overlapping end-markets but much greater scale and broader portfolio.
- Toray Industries (Nanofiber Business): Global Japanese materials conglomerate with advanced nanofiber and membrane technologies for filtration, water treatment, and healthcare. Broad incumbent with overlapping industrial filtration and biomedical nanofiber capabilities.
Emerging players
- Fiberio Technology Corporation: Emerging player in nanofiber production systems using proprietary rotary jet-spinning technology. Partial overlap as an alternative nanofiber manufacturing platform serving cosmetics, filtration, and biomedical applications.
- Bio-Byblos: European cosmetics brand leveraging nanofiber face mask technology comparable to Nanopharma's NanoBeauty line. Emerging competitor in the premium nanofiber cosmetic mask segment targeting European retail and spa channels.
Others
- Resomer (Evonik): Supplier of biodegradable polymers (PLA, PCL, PLGA) used by Nanopharma for electrospinning. Adjacent ecosystem participant as a feedstock provider for the regenerative medicine and 3D scaffold segments.
- Technical University of Liberec (CXI / Department of Nonwoven Textiles): Academic partner and laboratory host where Nanopharma's facilities reside. Not a direct competitor but a key enabling institution providing R&D infrastructure, talent pipeline, and collaborative research access for the company.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key highlights7 records
Customer concentration
Nanopharma social profiles
Digital presenceNanopharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nanopharma leadership team
Management profileNumber of profiles
Profiles9 records
Nanopharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nanopharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nanopharma
What does Nanopharma do?
Nanopharma is a nanomaterials engineering company that researches, develops, and produces customized nanofibrous structures using proprietary electrospinning technologies applied to natural and synthetic polymers. Its commercial offering combines contract research and contract manufacturing services (Technology Solutions division), branded nanofibrous cosmetic face masks under NanoBeauty, and NanoMatrix 3D biodegradable scaffolds for life science research, supported by in-house material characterization, biological testing, and skin diagnostics.
Is Nanopharma a public or private company?
Nanopharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Nanopharma founded?
Nanopharma was founded in 2008. It employs 1 to 10 people.
Where is Nanopharma based?
Nanopharma is headquartered in Pardubice, Czechia, in the Europe region.
How does Nanopharma make money?
Four revenue lines are on record. Custom R&D and contract research services are the primary driver. The others are technology licensing and know-how transfer, nanoBeauty cosmetic products and nanoMatrix 3D scaffolds.
Who are Nanopharma's main competitors?
Direct peers on record are Nanofiber Solutions, Elmarco, Finetex Envision and SNS Nano Fiber Technology. Broad incumbents are Asahi Kasei (Bemliese/Velutis nanofiber) and Toray Industries (Nanofiber Business). Emerging players are Fiberio Technology Corporation and Bio-Byblos. Others are Resomer (Evonik) and Technical University of Liberec (CXI / Department of Nonwoven Textiles).
Does Nanopharma have an API?
No public API is recorded for Nanopharma.
What industry is Nanopharma in?
Nanopharma's product category is Nanomaterials engineering. Its primary akta.pro industry code is HLAAAGAB, Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials), with a secondary code of IMANANAB, Bioplastics Compounding & Masterbatch (bio-based additives, colorants, fillers). Its NAICS code is 541713 and its SIC code is 3089.